Results 171 to 180 of about 42,049,725 (376)

MOQUI: an open-source GPU-based Monte Carlo code for proton dose calculation with efficient data structure. [PDF]

open access: yesPhys Med Biol, 2022
Lee H   +6 more
europepmc   +1 more source

A data structure and algorithm for fault diagnosis [PDF]

open access: yes
Results of preliminary research on the design of a knowledge based fault diagnosis system for use with on-orbit spacecraft such as the Hubble Space Telescope are presented.
Bosworth, Edward L., Jr.
core   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Structure Refinement of Ti5Sb3 from Single-crystal Data. [PDF]

open access: bronze, 1977
R. Berger   +5 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

open access: yesMolecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song   +11 more
wiley   +1 more source

qMRI-BIDS: An extension to the brain imaging data structure for quantitative magnetic resonance imaging data. [PDF]

open access: yesSci Data, 2022
Karakuzu A   +13 more
europepmc   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy